Pharvaris (PHVS)
(Delayed Data from NSDQ)
$19.51 USD
-1.58 (-7.49%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $19.38 -0.13 (-0.67%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Pharvaris NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -108.04 | -79.71 | -50.47 | -29.78 | NA |
Depreciation/Amortization & Depletion | 0.28 | 0.16 | 0.09 | 0.01 | NA |
Net Change from Assets/Liabilities | -6.35 | 8.83 | 1.86 | 1.80 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 13.40 | -0.04 | -4.25 | 3.42 | NA |
Net Cash From Operating Activities | -100.71 | -70.76 | -52.77 | -24.56 | NA |
Property & Equipment | -0.10 | -0.13 | -0.15 | -0.05 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | -0.10 | -0.13 | -0.15 | -0.05 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 371.13 | 10.12 | 185.54 | 117.10 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | -0.24 | -0.13 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | -18.72 | -0.88 | -15.56 | -1.50 | NA |
Net Cash from Financing Activities | 352.17 | 9.11 | 169.98 | 115.60 | NA |
Effect of Exchange Rate Changes | -3.10 | 11.72 | 13.94 | -1.55 | NA |
Net Change In Cash & Equivalents | 248.27 | -50.06 | 131.00 | 89.44 | NA |
Cash at Beginning of Period | 175.16 | 220.57 | 116.69 | 23.22 | NA |
Cash at End of Period | 423.43 | 170.51 | 247.69 | 112.66 | NA |
Diluted Net EPS | -2.85 | -2.39 | -1.66 | -6.12 | NA |
Fiscal Year End for Pharvaris NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -61.81 | -30.11 | -108.04 | -73.82 | -48.39 |
Depreciation/Amortization & Depletion | 0.15 | 0.07 | 0.28 | 0.21 | 0.13 |
Net Change from Assets/Liabilities | 3.62 | 1.77 | -6.35 | -7.80 | -7.94 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.14 | 1.96 | 13.40 | 6.05 | 6.37 |
Net Cash From Operating Activities | -55.91 | -26.31 | -100.71 | -75.36 | -49.82 |
Property & Equipment | -0.08 | -0.03 | -0.10 | -0.07 | -0.06 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.08 | -0.03 | -0.10 | -0.07 | -0.06 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.68 | 0.21 | 371.13 | 69.88 | 69.88 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -0.12 | -0.06 | -0.24 | -0.18 | -0.10 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.64 | 0.72 | -18.72 | -0.41 | -0.23 |
Net Cash from Financing Activities | 1.20 | 0.86 | 352.17 | 69.29 | 69.55 |
Effect of Exchange Rate Changes | 3.46 | 0.63 | -3.10 | 2.35 | -0.75 |
Net Change In Cash & Equivalents | -51.32 | -24.85 | 248.27 | -3.79 | 18.92 |
Cash at Beginning of Period | 421.32 | 424.76 | 175.16 | 176.14 | 176.47 |
Cash at End of Period | 370.00 | 399.91 | 423.43 | 172.36 | 195.39 |
Diluted Net EPS | -0.59 | -0.56 | -0.81 | -0.63 | -0.69 |